A study on injectable DMPA (Depomedroxy Progesterone Acetate) and effect of its use as a short term contraception in immediate postpartum women

https://doi.org/10.53730/ijhs.v7nS1.14195

Authors

  • Sofia Shah Medical Officer (Health Department), Diploma in Obstetrics and Gynaecology, District Malakand, Pakistan
  • Asia Asghar Medical Officer (Health Department), FCPS Obstetrics and Gynaecology, District Abbottabad
  • Seema Rafiq Medical Officer (Health Department), FCPS Obstetrics and Gynaecology District Kohat

Keywords:

postpartum women, injectable DMPA, contraceptive

Abstract

Background and Aim: Contraception in the postpartum period is a significant problem. When used correctly, injectable hormonal contraceptives are one of the most reliable methods of contraception currently available. The purpose of the present study was to assess the effect of injectable DMPA as a short term contraceptive in immediate postpartum women. Patients and Methods: This prospective observational study was conducted on 130 postpartum women in the Gynaecology Department of Ayub Teaching Hospital, Abbottabad from December 2018 to December 2019. The study group of 130 postpartum women were given injectable DMPA 150 mg intramuscularly during discharge from hospital and after three months. The mother was subjected to a complete general physical examination. The need of exclusive breast feeding was emphasized. Fasting blood samples were collected for liver function testing (LFT), lipid profile, blood sugar, haemoglobin (Hb). About 130 postpartum women who were not taking any hormonal contraceptive were considered a control group. All the patients were followed-up for six weeks, three months, and six months. Data analysis was done using SPSS version 27.  Results: The overall mean age of study group was 24.6±2.9 years with an age range 20 to 34 years. 

Downloads

Download data is not yet available.

References

Singhal S, Sarda N, Wadhawan D, Gupta S. SHORT TERM USE OF INJECTABLE DMPA FOR CONTRACEPTION IN IMMEDIATE POSTPARTUM WOMEN. Indian Obstetrics and Gynaecology. 2017 Apr 12;7(1).

Bairagya A, Basu G, Mondal R, Roy SK. Prevalence and reasons behind use of injectable contraceptive among the women of reproductive age group: A cross-sectional survey in rural areas of Nadia District, West Bengal. J Family Med Prim Care 2021;10:2566-71.

7. Khadilkar SS. Short term use of injectable contraception: An effective strategy for safe motherhood. J Obstet Gynaecol India 2018;68:82 7.

Rai L, Prabakar P, Nair S. Injectable depot medroxyprogesterone A safe and an effective contraception for an indian setting. Health and Population: Perspectives and Issues 2007; 30:12 23.

Ogboghodo EO, Adam VY, Wagbatsoma VA. Prevalence and determinants of contraceptive use among women of child bearing age in a rural community in Southern University of Benin, Benin City, Nigeria. Journal of Community Medicine and Primary Health Care 2017;29:97 107.

Pandey VK, Aggarwal P, Kakkar R. Modified BG Prasad’s socio economic classification 2018. The need of an update in the present scenario. Indian Comm Health 2018;30:82 4.

Doweraha J, Narayana Murthy MR, Kulkarnic P. Prevalence and pattern of contraceptive use and unmet need among women of reproductive age in urban Mysuru. Clin Epidemiol Glob Health 2020;5:1221 4.

MacLachlan E, Atuyambe L, Millogo T, Guiella G, Yaro S, Kasasa S, et al. Continuation of subcutaneous or intramuscular injectable contraception when administered by facility based and community health workers: Findings from a prospective cohort study in Burkina Faso and Uganda. Contraception 2018;98:423 9.

Oumer M, Manaye A, Mengistu Z. Modern contraceptive method utilization and associated factors among women of reproductive age in Gondar City, Northwest Ethiopia. Open Access J Contracept 2020;11:53 67.

McCullough DC, Eraso KM, Kaunitz AM. Depot Medroxyprogesterone Acetate. The Handbook of Contraception: Evidence Based Practice Recommendations and Rationales. 2020:97-116.

Dim C, Ugnu E, Illoghalu E. Duration and determinants of interdelivery interval among women in Enugu,south eastern Nigeria. Journal of Obstetrics and Gynaecology. 2013;33:175-79.

ACOG Practice Bulletin No. 206. Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2019;133(2):e128–50.

Braga GC, Ferriolli E, Quintana SM, et al. Immediate postpartum initiation of etonogestrel-releasing implant: a randomized controlled trial on breastfeeding impact. Contraception. 2015;92(6):536–42.

Phillips SJ, Tepper NK, Kapp N, Nanda K, Temmerman M, Curtis KM. Progestogen-only contraceptive use among breastfeeding women: a systematic review. Contraception. 2016;94(3):226–52.

Huang YM, Merkatz R, Kang JZ, Roberts K, Hu XY, Di Donato F, et al. Postpartum unintended pregnancy and contraception practice among rural to urban migrant women in Shanghai. Contraception 2012; 86(6):731-8.

Westhoff C. Depot medroxyprogesterone acetate injection (Depo Provera): a highly effective contraceptive option with proven long term safety. Contraception 2003; 68(2):75-87.

Malarcher S, Meirik O, Lebetkin E, Shah I, Spieler J, Stanback J. Provision of DMPA by community health workers: what the evidence shows. Contraception 2011; 83(6):495-503.

Pal R, Maheshwari S, Kaka N, Patel N, Sethi Y. Knowledge, Attitude and Practices of Postpartum Females Regarding the Acceptance of Immediate Postpartum Contraception: A Cross-Sectional Study From North India. Cureus. 2022 Oct 2;14(10).

Pal R, Maheshwari S, Kaka N, Patel N, Sethi Y. Knowledge, Attitude and Practices of Postpartum Females Regarding the Acceptance of Immediate Postpartum Contraception: A Cross-Sectional Study From North India. Cureus. 2022 Oct 2;14(10).

Damtie Y, Kefale B, Yalew M, Arefaynie M, Adane B: Short birth spacing and its association with maternal educational status, contraceptive use, and duration of breastfeeding in Ethiopia. A systematic review and meta-analysis. PLoS One. 2021, 16:e0246348. 10.1371/journal.pone.0246348.

Collier AY, Molina RL: Maternal mortality in the united states: updates on trends, causes, and solutions. Neoreviews. 2019, 20:e561-74. 10.1542/neo.20-10-e561.

Grisaru-Granovsky S, Gordon ES, Haklai Z, Samueloff A, Schimmel MM: Effect of interpregnancy interval on adverse perinatal outcomes--a national study. Contraception. 2009, 80:512-8. 10.1016/j.contraception.2009.06.006 India National Family Health Survey (NFHS-5). (2021). http://rchiips.org/nfhs/.

Idowu A, Deji SA, Ogunlaja O, Olajide SO: Determinants of intention to use post partum family planning among women attending immunization clinic of a tertiary hospital in Nigeria. Am J Public Health Res. 2015, 3:10.12691/ajphr-3-4-1

Jalang'o R, Thuita F, Barasa SO, Njoroge P: Determinants of contraceptive use among postpartum women in a county hospital in rural Kenya. BMC Public Health. 2017, 17:604. 10.1186/s12889-017-4510-6

Thapa K, Dhital R, Rajbhandari S, et al.: Prevalence of postpartum family planning service coverage in selected referral facilities of Nepal. JNMA J Nepal Med Assoc. 2020, 58:1-5.

Bajracharya A: Knowledge, attitude and practice of contraception among postpartum women attending Kathmandu Medical College Teaching Hospital. Kathmandu Univ Med J (KUMJ). 2015, 13:292-7. 10.3126/kumj.v13i4.16826

Mengesha ZB, Worku AG, Feleke SA: Contraceptive adoption in the extended postpartum period is low in Northwest Ethiopia. BMC Pregnancy Childbirth. 2015, 15:160. 10.1186/s12884-015-0598-9.

Kotecha PV, Patel SV, Baxi RK, Kapadia S, Mehta K. Women’s and providers’ experiences with injectable contraceptives (Depo provera): A view from Vadodara, India. Indian Journal of Clinical Practice 2020;31:152 6.

Barrow A. A survey on prevalence and knowledge of family planning among women of childbearing age in the provincial settings of the Gambia: A descriptive cross sectional study. Advances in Preventive Medicine. [Last Cited 2021 Apr 03] Available from: https://www.hindawi.com/journals/apm/2020/8862290/.

Rani S. A study on injectable DMPA (Depomedroxy progesterone acetate) isomg use as short term contraception in immediate postpartum women. International Journal of Medical and Health Research 2017;3:17 22.

Kochar S, Kumar A, Nama A, Suthar N. A prospective study to know the efficacy of short-term use of injectable depot medroxy progesterone acetate for contraception in tertiary care hospital from North West Rajasthan, India. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2020 Jun 1;9(6):2482-6.

Published

02-05-2023

How to Cite

Shah, S., Asghar, A., & Rafiq, S. (2023). A study on injectable DMPA (Depomedroxy Progesterone Acetate) and effect of its use as a short term contraception in immediate postpartum women. International Journal of Health Sciences, 7(S1), 296–304. https://doi.org/10.53730/ijhs.v7nS1.14195

Issue

Section

Peer Review Articles